THE IMPORTANCE OF BODY COMPOSITION MEASUREMENTS DURING LENVATINIB TREATMENT IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

被引：0

作者：

Yamaoka, Kenji ^{[1
]}

Kawaoka, Tomokazu ^{[1
]}

Kosaka, Masanari ^{[1
]}

Johira, Yusuke ^{[1
]}

Shirane, Yuki ^{[1
]}

Miura, Ryoichi ^{[1
]}

Yano, Shigeki ^{[1
]}

Murakami, Serami ^{[1
]}

Amioka, Kei ^{[1
]}

Naruto, Kensuke ^{[1
]}

Ando, Yuwa ^{[1
]}

Kosaka, Yumi ^{[1
]}

Uchikawa, Shinsuke ^{[1
]}

Kodama, Kenichiro ^{[1
]}

Uchida, Takuro ^{[1
]}

Fujino, Hatsue ^{[1
]}

Ono, Atsushi ^{[1
]}

Nakahara, Takashi ^{[1
]}

Murakami, Eisuke ^{[1
]}

Okamoto, Wataru ^{[2
]}

Yamauchi, Masami ^{[1
]}

Miki, Daiki ^{[1
]}

Imamura, Michio ^{[1
]}

Chayama, Kazuaki ^{[3
]}

Aikata, Hiroshi ^{[1
]}

机构：

[1] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan

[2] Hiroshima Univ, Canc Treatment Ctr, Hiroshima, Japan

[3] Hiroshima Univ, Dept Collaborat Res Lab Med Innovat, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

4508

引用

页码：S1386 / S1387

页数：2

共 50 条

[21] The efficacy and adverse effects of nivolumab and lenvatinib in the treatment of advanced hepatocellular carcinoma
Wen, Shilai
Zeng, Jingke
Zhong, Liting
Ye, Jianmin
Lai, Xiaohuan
CELLULAR AND MOLECULAR BIOLOGY, 2022, 68 (11) : 53 - 57
[22] Lenvatinib treatment for advanced hepatocellular carcinoma: The relationship between efficacy and safety
Oikawa, T.
Yusa, K.
Okamoto, T.
Yonezawa, M.
Satou, T.
Abe, T.
Endo, K.
Sawara, K.
Kuroda, H.
Takikawa, Y.
ANNALS OF ONCOLOGY, 2019, 30
[23] Bowel Perforation in a Patient with Hepatocellular Carcinoma during Lenvatinib Treatment
Mizokami, Ken
Watanabe, Akiko
Yamaguchi, Eriko
Saito, Akira
CASE REPORTS IN GASTROENTEROLOGY, 2022, 16 (02) : 502 - 506
[24] Pneumothorax during lenvatinib treatment for hepatocellular carcinoma with lung metastasis
Yasuhiro Kawanishi
Michio Kuwahara
Masato Utsunomiya
Nobuko Ishida
Yoichi Ishikawa
Makoto Hiroi
Toyokazu Akimori
Clinical Journal of Gastroenterology, 2021, 14 : 288 - 292
[25] Pneumothorax during lenvatinib treatment for hepatocellular carcinoma with lung metastasis
Kawanishi, Yasuhiro
Kuwahara, Michio
Utsunomiya, Masato
Ishida, Nobuko
Ishikawa, Yoichi
Hiroi, Makoto
Akimori, Toyokazu
CLINICAL JOURNAL OF GASTROENTEROLOGY, 2021, 14 (01) : 288 - 292
[26] Factors Raising Serum Ammonia Level During Lenvatinib Treatment of Patients With Hepatocellular Carcinoma
Narita, Ryoichi
Kotoh, Kazuhiro
Yoneda, Akitoshi
Motomura, Mitsuteru
Harada, Masaru
ANTICANCER RESEARCH, 2020, 40 (09) : 5271 - 5276
[27] Lenvatinib: a potential breakthrough in advanced hepatocellular carcinoma?
Oikonomopoulos, Georgios
Aravind, Preetha
Sarker, Debashis
FUTURE ONCOLOGY, 2016, 12 (04) : 465 - 476
[28] The immunomodulatory activity of lenvatinib prompts the survival of patients with advanced hepatocellular carcinoma
Zhu, Jie
Fang, Peiqi
Wang, Chong
Gu, Meixiu
Pan, Baishen
Guo, Wei
Yang, Xinrong
Wang, Beili
CANCER MEDICINE, 2021, 10 (22): : 7977 - 7987
[29] Salvage Treatment of Nivolumab and Lenvatinib in Patients with Recurrent Hepatocellular Carcinoma
Zhou, Lijun
Peng, Wei
Duan, Huaxin
Deng, Tan
HEPATITIS MONTHLY, 2023, 23 (01)
[30] Prognostic Impact of Surgical Intervention After Lenvatinib Treatment for Advanced Hepatocellular Carcinoma
Shindoh, Junichi
Kawamura, Yusuke
Kobayashi, Yuta
Kobayashi, Masahiro
Akuta, Norio
Okubo, Satoshi
Suzuki, Yoshiyuki
Hashimoto, Masaji
ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (12) : 7663 - 7672

← 1 2 3 4 5 →